Clinical Medicine Research

Special Issue

Epigenetic Modification of Essential Hypertension Gene and Gene Therapy

  • Submission Deadline: 1 December 2022
  • Status: Submission Closed
  • Lead Guest Editor: Zhi xiong Zhong
About This Special Issue
Essential hypertension is a multi-gene hereditary disease which is affected by heredity, environment and nutrition. The study of essential hypertension should not be limited to the risk factors of hypertension: high sodium diet, alcoholism, smoking, obesity, diabetes, mental stress, gene polymorphism, but more attention should be paid to epigenetics of essential hypertension. Why does the environment influence the selective expression of essential hypertension genes? Epigenetic modification of hypertension plays a big role. And the effect may be passed down to the next generation. Epigenetics of essential hypertension include DNA methylation, histone modification, non-coding RNA, etc. The goal of this special issue is to gather the latest research results of hypertension gene research, hypertension epigenetics, and hypertension gene therapy, and find the treatment plan for essential hypertension according to the gene and gene expression.


  1. Essential Hypertension
  2. Hypertension Gene
  3. Epigenetics of Hypertension Genes
  4. Epigenetic Modification
  5. Hypertension Gene Therapy
  6. Hypertension Gene Polymorphism
Lead Guest Editor
  • Zhi xiong Zhong

    The First People's Hospital of Shaoguan, Shao Guan, China

Guest Editors
  • Zhi chao Qiu

    The First People's Hospital of Shaoguan, Shao Guan, China

  • Long Zeng

    Chenzhou First People's Hospital, Chen zhou, China

  • Xue wen Wang

    Renmin hospital of Wuhan University, Wu Han, China

  • Chao Jun Wei

    Department of Cardiovascular Medicine, Affiliated Hospital of Guizhou Medical University, Gui yang, China

  • Juan Tan

    Bazhong Central Hospital, Ba Zhong, China

  • Luo Chao Zhang

    Xinxiang Central Hospital, Xin Xiang, China